TYVASO for Pulmonary hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where TYVASO was used for Pulmonary hypertension.
Most Reported Side Effects for TYVASO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 124 | 23.7% | 123 | 7 |
| Dyspnoea | 69 | 13.2% | 2 | 55 |
| Pneumonia | 44 | 8.4% | 5 | 42 |
| Cough | 37 | 7.1% | 2 | 13 |
| Headache | 32 | 6.1% | 0 | 17 |
| Fluid retention | 26 | 5.0% | 1 | 23 |
| Chest pain | 22 | 4.2% | 0 | 15 |
| Dizziness | 22 | 4.2% | 0 | 12 |
| Pulmonary arterial hypertension | 21 | 4.0% | 7 | 14 |
| Anaemia | 15 | 2.9% | 0 | 13 |
| Oxygen saturation decreased | 15 | 2.9% | 1 | 11 |
| Condition aggravated | 13 | 2.5% | 1 | 10 |
| Diarrhoea | 13 | 2.5% | 1 | 7 |
| Fall | 13 | 2.5% | 0 | 11 |
| Fatigue | 13 | 2.5% | 1 | 3 |
Other Indications for TYVASO
Pulmonary arterial hypertension (273)
Cor pulmonale chronic (143)
Product used for unknown indication (56)
Other Drugs Used for Pulmonary hypertension
AMBRISENTAN (18,885)
TREPROSTINIL (10,034)
MACITENTAN (5,228)
RIOCIGUAT (3,837)
SILDENAFIL (3,761)
SELEXIPAG (2,500)
EPOPROSTENOL (2,486)
TADALAFIL (2,430)
BOSENTAN (2,337)
ILOPROST (1,123)